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t R26-8 is a tetracycline-sensitive mutant of R26.
$R55-1 and R57b-1 are segregants of R55 and R57b, respectively; they still confer resistance to 6 R6-S, R478 and R71a determine the production of type I CAT.
1 1 R26-8con and R57b-lcon are mutants of R26-8 and R57b-1 that express chloramphenicol resistance Km, kanamycin; Sm, streptomycin; Su, sulphonamides; Tc, tetracycline.
chloramphenicol but no longer produce CAT.
constitutively.
follows. Exponential phase broth cultures of strains carrying the plasmids were mixed and incubated at 37 OC for 120 min. The strain carrying R478 + R26-8con was selected by streaking on agar containing tetracycline and ampicillin, and the strain harbouring R6-S + R57b-lcon was selected on tetracycline and sulphonamide.
Bacteriological media and antibiotics. The composition of the nutrient broth and agar was described by Foster & Walsh (1974) and that of the minimal medium by Foster & Willetts (1976) . Buffered sucrose minimal medium contained sucrose (0.5 M), double-strength minimal salts (Foster & Willetts, 1976) , glucose (1 %, w/v), proline and methionine (60 pg ml-l each); the pH of the medium was 6.5. Chloramphenicol, tetracycline and sulphanilamide were from Sigma. Ampicillin was a gift from Beechams. All other chemicals were either from Sigma or the best grade available from BDH.
Resistance level determinations. Resistance levels to chloramphenicol were determined as described by Gaffney et al. (1978) . The resistance level was defined as the concentration of drug preventing the formation of single colonies.
Isolation of mutants of R5 7b-I and R26-8 that expressed chloramphenicol resistance constitutively. Constitutive mutants were selected by an adaptation of a method used for selecting mutants that expressed plasmid-determined tetracycline resistance constitutively (Foster, 1977) . Cultures growing exponentially in 50 ml volumes of broth were challenged with chloramphenicol (125 pg ml-l for R57b-1; 60 pg ml-I for R26-8) and shaken overnight at 37 OC. A sample of cells was washed in saline, added to fresh broth, incubated for 2 h and then mixed with an equal volume of an exponential phase broth culture of strain DU1000 (Str'). After overnight incubation the mating mixture was diluted in fresh broth and grown for 2 h before treatment with chloramphenicol (the same concentrations as above) and streptomycin (500 pg ml-l). After overnight growth the survivors were streaked on chloramphenicol plates and individual colonies were tested for constitutive expression of chloramphenicol resistance by a broth growth and challenge procedure (Foster & Walsh, 1974) . This method should specifically enrich plasmid-linked mutants expressing chloramphenicol resistance constitutively.
Preparation and assay of chloramphenicol acetyltransferase (CAT). The CAT activity of crude cell lysates was determined as described by Gaffney et al. (1978) . CAT activity was assayed by the spectrophotometric method of Shaw & Brodsky (1968) .
Bioassay of chloramphenicol in culture supernatants. Cultures were grown overnight in broth containing 50 pg chloramphenicol ml-l. Bacteria were then removed by centrifugation and the supernatant was heated at 90 OC for 5 min. Dilutions were pipetted into wells in nutrient agar plates previously spread with a dilution of an exponential phase culture of E. coli K12. The zones of inhibition of the bacterial growth were measured and compared with those for standard chloramphenicol solutions.
Growth of strains in [14Clchloramphenicol. Portions of overnight broth cultures (0.1 ml) were added to 1.0 ml broth containing ~-threo-[dichloroacetyl-1-~~Clchloramphenic0l [ 2 pg ml-l, 0-05 pCi ml-l, 7.94 mCi mmol-l (294 MBq mmol-I); The Radiochemical Centre, Amershaml. After overnight incubation the entire culture was supplemented liquid minimal medium and resuspended to the same density in fresh medium with or without chloramphenicol (1 pg ml-l). Samples (1 ml) were challenged with chloramphenicol (10-100 pg ml-l) followed immediately by 0.1 pCi L-[ l-'4Clleucine [50 mCi mmol-' (1.85 GBq mmol-l); The Radiochemical Centre, Amershaml. The contents of the tubes were mixed with an equal volume of 10% (w/v) ice-cold trichloroacetic acid (TCA) and after 30 min on ice the precipitates were filtered on glass-fibre filters (Whatman GF/C), washed twice with 5 ml volumes of 5 % TCA and dried in an oven. Scintillation fluid [5 ml of 0.6 % (w/v) 2,5-diphenyloxazole in toluene] was added and the TC A-precipitable radioactivity was measured in a Packard Tricarb liquid scintillation spectrometer. Preparation of spheroplasts. Spheroplasts were prepared by the method of Osborn & Munson (1974) . Cells were grown to A,,, 0.8 in 100 ml supplemented liquid minimal medium, and then pelleted and resuspended in 25 ml ice-cold buffered sucrose minimal medium. A 10 mi sample was removed, diluted with an equal volume of sterile distilled water and used as a control for monitoring [14Clleucine uptake into whole cells. To the remaining suspension, lysozyme (0.5 ml of a freshly prepared 2 mg ml-l solution) was added, followed 2 min later by the gradual addition with shaking of 10 ml 2 mM-EDTA. After 30 min a portion was removed for phase contrast microscopy and viable counting, which indicated 75-85 % conversion to spheroplasts. [14ClLeucine incorporation into whole cells and spheroplasts following challenge with chloramphenicol was determined as described above.
In vitro polypeptide synthesis. Cells carrying R26 or R57b-1 were grown for 4 h in Oxoid nutrient broth no. 2 with or without chloramphenicol (1 pg ml-l). The cells were harvested by centrifugation at 5000 g, washed twice in RS buffer (10 mM-Tris/HCl pH 7.6 at 20 "C, 10 m~-MgCl,, 50 mM-NH,Cl. 3 m~-2-mercaptoethanol) and finally resuspended in RS buffer (500 mg wet wt ml-l). Lvsis was achieved by grinding cells in a chilled mortar with an equal weight of Levigated Alumina (Norton Abrasives, Welwyn Garden City). The extract was treated with deoxyribonuclease (5 pg ml-l) at 0 OC for 5 min. An S30 ribosome-containing fraction was prepared by centrifugation at 30000 g for 30 min. The assay for cell-free polypeptide synthesis was as follows. First, the S30 fraction was pre-incubated to remove endogenous mRNA for 20 min at 37 OC in the following reaction mixture:
N-2-hydroxyethylpiperazine-N'-2-ethane sulphonic acid (HEPES)/KOH (pH 7 -5), 20 mM; (CH,COO),Mg, 12 mM; CH3COONH4, 150 mM; ATP, 2 mM; GTP, 0.5 mM; phosphoenolpyruvate, 20 mM. The assay contained: the above reagents, at the same concentration; all 19 L-amino acids (except valine), each at 170 mM; unfractioned E. coli tRNA, 0.8 mg ml-l; [14C]valine (285 mCi mmol-', 10.55 GBq mmol-'), 4 pCi ml-l; poly(U.G) (1 : 1 + 2: 1 U:G), 70 pg ml-l. The final S30 concentration was 6 units per 100 p1. Chloramphenicol was added in the range of 2-250 pg ml-l. Samples (5 pl) were removed at intervals into 10% TCA and heated at 90 "C for 20 min.
The precipitates were collected on Whatman GF/C discs and the radioactivity was determined using a toluene/2-phenyl-5-(4-biphenylyl)-1,3,4-oxadiazole (PBD) scintillation fluid.
R E S U L T S
Chloramphenicol resistance plasmids that do not encode chloramphenicol acetyltransferase In a previous paper (Gaffney et al., 1978) we showed that cells carrying the chloramphenicol resistance plasmids R26, R527, R55-1, R57b-1 and RA 1-1 b did not specify CAT. When strains carrying these plasmids had been exposed to a low concentration of the drug (1 yg ml-l), they grew at higher drug concentrations in resistance level determinations on solid media, suggesting that the expression of resistance might be inducible (Table 2 ). This was confirmed by measuring [ 14C]leucine incorporation into cellular protein in the presence of chloramphenicol(10-100 yg ml-I) (Fig. 1) . Uninduced cultures incorporated less [ 14Clle~cine into cellular protein when challenged with high drug concentrations. Figure 1 shows the results obtained with R26 and R55-1; the other plasmids (R527, R57b-1 and RA1-lb) behaved similarly (D. Gaffney, unpublished data) . Uninduced cultures of strains carrying the constitutive mutants R26-8con and R57b-lcon responded in a similar fashion to induced cultures of strains carrying the corresponding parent plasmids.
Chloramphenicol-resistant cells do not degrade the drug
Strains carrying the chloramphenicol resistance plasmids were grown overnight in broth containing chloramphenicol (50 pg ml-l) or [ 14Clchloramphenicol. The antibiotic activity in * Cultures were induced by growth in broth containing 1 pg chloramphenicol ml-l. chloramphenicol(1 yg ml-l). Samples were challenged with different concentrations of chloramphenicol (10-100 pg ml-l) followed immediately by [ l4Clleucine (0.1 pCi ml-l). The percentage inhibition of incorporation of [ 14Clleucine into TCA-precipitable material compared with the untreated control was measured.
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culture supernatants was measured by bioassay ( Table 3 ) or extracts of the radioactive culture were chromatographed on thin-layer alumina plates (Fig. 2) . The bioassay experiment showed that the antibiotic was not inactivated after overnight growth of cells carrying R5 7b-lcon or R26-8con in chloramphenicol broth. However, the drug was completely destroyed in cultures of strains carrying the plasmids R6-S or R478, which code for CAT ( Table 3) . Autoradiography of the ethyl acetate extracts of cells grown in [14Clchloramphenic~l did not reveal any altered forms of the drug, whereas extracts from the CAT+ control culture showed several spots presumably corresponding to acetylated derivatives (Fig. 2) .
Strains carrying a CAT+ plasmid and a constitutive mutant of R57b-1 or R26-8 were constructed. Constitutive mutants were used to ensure that the normally inducible non-CAT resistance mechanism was expressed in the CAT+ cells. It was not certain if the acetylated derivative of chloramphenicol would serve as an inducer of the other resistance determinant.
Plating tests demonstrated that the strains carrying R6-S + R57b-lcon and R478 + R26-8con did not show a markedly elevated resistance level (Table 3) . Thus, no synergism occurs between the two mechanisms of resistance.
Bioassay of the culture supernatants of the strains carrying R6-S + R57b-1con or R478 + R26-8con grown overnight in broth containing 50 pg chloramphenicol ml-I showed only Extracts of the cultures were subjected to thin-layer chromatography and autoradiography as described in Methods. F1 and F2 indicate the positions of the two solvent fronts. Track 1 contains the extract of 55-3 without a plasmid; track 2, R527; track 3, R57b-lcon; track 4, R55-1; track 5, uninoculated broth; track 6, RA1-lb; track 7, R26; track 8, R71a (CAT+); track 9, R57b-1; track 10, R26-8. marginal inactivation of the drug. In the R6-S and R478 controls all the drug was destroyed, whereas R5 7b-lcon and R26-8~0n cultures contained the original concentration of active chloramphenicol ( Table 3) . Controls were performed to ensure that cells carrying R6-S + R57b-lcon and R478 + R26-8con contained the normal amount of intracellular CAT (Table   3) , and mating experiments showed that both plasmids were present independently in these strains. These experiments suggest that the chloramphenicol in the medium could not penetrate to the intracellular CAT because the second resistance mechanism prevented its transport into the cell. Strains carrying plasmid R55, which codes for both types of chloramphenicol resistance determinant, also failed to inactivate the drug.
Effect of spheroplast formation on the expression of chloramphenicol resistance
Spheroplasts derived from bacteria carrying the chloramphenicol resistance plasmids were tested for the expression of resistance by monitoring the incorporation of [l4CIleucine into cellular protein in the presence of chloramphenicol. No difference was detected between the protein-synthesizing ability of the whole cells and spheroplasts in the presence of high drug concentrations showing that the resistance mechanism was not perturbed by this treatment. Figure 3 shows results obtained for R57b-1; similar results were obtained for the other chloramphenicol resistance plasmids (D. Gaffney, unpublished data).
Effect of the cmlB mutation on the level of chloramphenicol resistance specijied by the plasmids Escherichia coli cmlB mutants have an increased intrinsic level of resistance to chloramphenicol caused by an alteration in outer membrane structure which impairs drug uptake (Chopra & Eccles, 1978) . The cmlB mutant envelope alteration is known to act synergistically with plasmids specifying intracellular CAT and also with plasmids encoding tetracycline resistance (Foster, 19 75) . The chloramphenicol resistance levels determined by the plasmids R55-1, R57b-1, R527 and R26 in strain RE107 (cmlB) and the parental strain RE1 were measured (Table 4) between the putative outer membrane alteration of the cmlB strain and the resistance mechanism encoded by the plasmids.
In vitro polypeptide synthesis
Ribosomes isolated from bacteria carrying plasmid R26 or R57b-1 were tested in an in vitro poly (U,G)-directed protein-synthesizing system in the presence of chloramphenicol. There was no detectable difference in the inhibition by chloramphenicol of CI4C lvaline incorporation into TC A-precipitable material whether the ribosomes used were from uninduced or induced cells carrying R57b-1 (Fig. 4) . Similar results were obtained for ribosomes isolated from strain 55-3 carrying R26 and from the plasmid-less host (E.
Cundliffe, unpublished data).
D I S C U S S I O N
There are several striking differences between the two types of chloramphenicol resistance mechanisms encoded by plasmids from Gram-negative bacteria. The commonest mechanism of resistance is inactivation of the drug by CAT, a constitutively produced intracellular enzyme. The second mechanism, which is less widely encountered, is inducible and does not cause detectable inactivation of the drug. The results reported here suggest that the mechanism of resistance encoded by the plasmids that do not determine CAT is a barrier, probably located at the cytoplasmic membrane, which prevents the drug from reaching its intracellular target. Attempts to demonstrate reduced uptake of [ 14C]chloramphenic~l into resistant cells were not successful. This was because of the difficulty in reliably demonstrating drug uptake into sensitive cells. Chloramphenicol is not concentrated in E. coli cells in the same way as tetracycline and is apparently washed out very easily. The fact that chloramphenicol was not destroyed or altered in its chromatographic properties after overnight growth of resistant cells in drug-containing broth shows that antibiotic inactivation is not responsible for resistance.
Spheroplasts formed by lysozyme-EDTA treatment exhibited the same levels of chloramphenicol resistance as intact cells. Similar results were obtained with spheroplasts prepared by growth in glycine medium and also with osmotically shocked cells (D. Gaffney, unpublished data) . This suggests that the resistance mechanism is not located in the outer membrane or peptidoglycan layers. Our results differ from those of Nagai & Mitsuhashi
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(1972) who reported that spheroplasts formed during growth of R+ cells in glycine-containing broth were sensitive to the drug. The reason for this difference is not understood. It is possible that the resistance mechanism studied by Nagai & Mitsuhashi (1972) was different from that reported here.
Cells carrying two plasmids, one specifying the intracellular chloramphenicol acetylating enzyme and the other a constitutive mutant of R57b-1 or R26-8, did not inactivate chloramphenicol in the culture medium. This indicates that the second mechanism prevented the drug from reaching the cytoplasmic CAT. This could be due to a barrier to the transport of the drug across the cytoplasmic membrane. However, we cannot explain our failure to demonstrate synergy between the two resistance mechanisms in terms of the resistance levels of strains carrying both types of plasmid, particularly when the chromosomal cmZB mutation, which results in a change in outer membrane structure (Chopra & Eccles, 1978) and causes about a twofold increase in the intrinsic chloramphenicol resistance level of E. coZi, acts synergistically with CAT+ R plasmids (Foster, 1975) . However, the cmZB mutation did act synergistically with resistance specified by R57b-1 and R26. This could be explained by two different permeability barriers acting together at different levels in the outer layers of the cell.
The target for chloramphenicol within the bacterial cell is the 50s subunit of the ribosome where it inhibits peptidyltransferase activity (Pestka, 19 7 1). A plasmid-specified change in ribosome structure analogous to that responsible for macrolide resistance in Gram-positive bacteria (Lai & Weisblum, 197 1) could also cause chloramphenicol resistance. However, chloramphenicol inhibited the ability of ribosomes from resistant and sensitive cells to support in vitro synthesis of polypeptides and thus a ribosomal mechanism seems unlikely.
The most likely mechanism of resistance to chloramphenicol determined by the plasmids studied here is a change in the structure of the cytoplasmic membrane, possibly by the action of a plasmid-specified protein in a similar fashion to plasmid-encoded tetracycline resistance (Levy & McMurry, 1974) . However, attempts to visualize proteins by polyacrylamide gel electrophoresis of envelope fractions, by crossed immunoelectrophoresis or using E. coli minicells have so far failed (D. Gaffney & T. J. Foster, unpublished data) . We suspect that resistance may be due to a protein which is either synthesized in small amounts or which is poorly antigenic.
The IncP-1 plasmids R26 and R527 determined a lower level of resistance to chloramphenicol in E. coZi than the IncC R factors R57b-1 and R55-1. The reason for this difference is not known. There may be differences in the mechanism by which the plasmids determine exclusion of chloramphenicol from bacteria which carry them. Alternatively, the R26 and R527 chloramphenicol resistance determinants might not be expressed well in the E . coli host. It seems unlikely that a gene dose effect caused by different copy numbers is involved. Both R26 and R5 7b-1 are large, presumably stringently replicating plasmids. R26 is 52 megadaltons and probably exists at about 3 copies per chromosome in E . coli, like RP4. R57b-1 is 89 megadaltons (Shapiro, 1977) and has a copy number of 0-5 (P. Barth, personal communication). A gene amplification mechanism involving tandem duplications is not a likely explanation because of the rapidity with which high level resistance to chloramphenicol is induced and because stable constitutive mutants have been isolated. 
